ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2265

NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies

Tineke Kraaij1, Sylvia Kamerling1, Jaap Bakker2, Francesca Brunini3, Charles Pusey3, Hans Ulrich Scherer4, René E.M. Toes5, Ton Rabelink1, Cees van Kooten1 and Onno Teng1, 1Nephrology, Leiden University Medical Center, Leiden, Netherlands, 2Clinical Chemistry, Leiden University Medical Center, Leiden, Netherlands, 3Imperial College, London, United Kingdom, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: ANCA, Neutrophil Extracellular Traps and neutrophils

Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophil extracellular traps (NETs) play an important role in the pathogenesis of ANCA-associated vasculitis (AAV). Sera of MPO-ANCA or PR3-ANCA positive patients can induce NETs In vitro. The present study aimed to investigate whether NET induction could serve as a biomarker in MPO- and PR3-positive AAV patients.

Methods: Healthy neutrophils were stimulated with 10% serum from 62 GPA patients, 37 MPA patients and 18 healthy subjects. NETs were stained with Sytox and imaged by automated 3D confocal laser scanning microscopy and quantified with digital image analysis. NET-inducing capacity was defined as the fold increase of quantified NETs relative to healthy control. To investigate NET induction by ANCA autoantibodies, IgG was isolated from sera using protein G agarose beads after which depletion of IgG in the flow through was confirmed with ELISA.

Results: Both GPA and MPA samples showed significantly higher NET-inducing capacity (fold change mean±SEM for GPA 40±7.4, p<0.0001 and for MPA 153.2±44.9, p<0.01). MPA sera had a significantly higher NET-inducing capacity than GPA (p<0.0001). In 14 AAV patients who had seroconverted, we observed that the NET-inducing capacity returned to levels of healthy controls (1.40±0.42, p=0.37). However, we found no correlation of NET-inducing capacity with titers of MPO and PR3 antibodies (r=0.17, p=0.35 for MPO and r=-0.04, p=0.79 for PR3). To further determine whether NET release was mediated by ANCA autoantibodies, we isolated MPO-ANCA IgG and PR3-ANCA IgG from 5 different sera. These purified IgG antibodies did not show NET-inducing capacity (1.40±0.33, p=0.45). In contrast, corresponding IgG-depleted sera had similar NET-inducing capacity as whole sera (12.91±4.5 for IgG-depleted sera and 18.88±7.26 for whole sera, p=0.51).

Conclusion: These data show that NET release in AAV patients is independent of MPO-ANCA or PR3-ANCA. Therefore, these data indicate that NET release might be a novel biomarker of AAV that is independent of ANCA autoantibodies. Our data supports the hypothesis that NETs are a source of autoantigens for the production of ANCA.


Disclosure: T. Kraaij, None; S. Kamerling, None; J. Bakker, None; F. Brunini, None; C. Pusey, Cell Medica Scientific Advisory Board, 9,Amgen Scientific Advisory Board; Editorial boards Journal of the American Society for Nephrology; Nephrology Dialysis Transplantation; Nephron, 9; H. U. Scherer, BristolMeyrs Squibb, The Netherlands, 9,Pfizer BV, The Netherlands, 9; R. E. M. Toes, None; T. Rabelink, None; C. van Kooten, None; O. Teng, None.

To cite this abstract in AMA style:

Kraaij T, Kamerling S, Bakker J, Brunini F, Pusey C, Scherer HU, Toes REM, Rabelink T, van Kooten C, Teng O. NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/net-inducing-capacity-is-a-biomarker-in-anca-associated-vasculitis-independent-of-anca-antibodies/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/net-inducing-capacity-is-a-biomarker-in-anca-associated-vasculitis-independent-of-anca-antibodies/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology